ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,863Medicare Part D Prescriptions Filled, Including Refills

Rank: 236 out of 973

$448K Total Retail Price of All Prescriptions

Rank: 188 out of 973

287 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 287 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 287 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,120 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 370 362 1 1
ATORVASTATIN CALCIUM 367 332 2 15
LISINOPRIL 361 340 3 3
LEVOTHYROXINE SODIUM 256 219 4 2
INDAPAMIDE 251 239 5 214
CRESTOR 234 224 6 34
OMEPRAZOLE 230 201 7 5
WARFARIN SODIUM 198 196 8 10
SPIRONOLACTONE 165 149 9 49
METFORMIN HCL 161 144 10 8
HYDROCODONE-ACETAMINOPHEN 160 159 S3 11 4
LOSARTAN POTASSIUM 159 143 12 19
FUROSEMIDE 143 135 13 6
LANTUS 142 127 14 39
AMLODIPINE BESYLATE 138 132 15 7
METOPROLOL TARTRATE 131 127 16 13
GABAPENTIN 121 109 17 12
METOPROLOL SUCCINATE 113 102 18 17
CITALOPRAM HBR 110 97 19 14
TAMSULOSIN HCL 104 88 20 28
QUETIAPINE FUMARATE 98 65 21 70
SYNTHROID 90 86 22 50
NAMENDA 88 88 23 31
DONEPEZIL HCL 80 80 24 26
SERTRALINE HCL 80 80 24 21
FAMOTIDINE 77 77 26 61
PREDNISONE 75 58 27 33
HUMALOG 69 58 28 127
ALLOPURINOL 66 62 29 29
ATENOLOL 65 65 30 16
CARVEDILOL 64 63 31 27
ESCITALOPRAM OXALATE 64 45 31 68
NITROGLYCERIN PATCH 62 62 33 173
PRAMIPEXOLE DIHYDROCHLORIDE 56 54 34 152
AMITRIPTYLINE HCL 55 16 R 35 52
SOTALOL 52 52 36 178
ZOLPIDEM TARTRATE 51 46 37 20
IPRATROPIUM-ALBUTEROL 51 51 37 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.